Table I.
Demographic and Clinical Manifestations Observed in RSV‐Infected Adults
RSV‐A (N = 43) | RSV‐B (N = 29) | P values | |
---|---|---|---|
Age, median (range) | 45 (18–83) | 46 (20–75) | 0.68 |
Male | 19 (44.2%) | 13 (44.8%) | 0.96 |
Symptoms and signs | |||
Pharyngeal congestion | 40 (93.0%) | 26 (89.7%) | 0.61 |
Chills | 36 (83.7%) | 19 (65.5%) | 0.07 |
Headache | 32 (74.4%) | 23 (79.3%) | 0.63 |
Myalgia | 30 (69.8%) | 17 (58.6%) | 0.33 |
Rhinorrhea | 26 (60.5%) | 17 (58.6%) | 0.88 |
Sore throat | 26 (60.5%) | 16 (55.2%) | 0.66 |
Cough | 23 (53.5%) | 18 (62.1%) | 0.47 |
Sneezing | 19 (44.2%) | 13 (44.8%) | 0.96 |
Expectoration | 16 (37.2%) | 11 (37.9%) | 0.95 |
Rigors | 6 (14.0%) | 2 (6.9%) | ND* |
Swelling of tonsils | 3 (7.0%) | 3 (10.3%) | ND |
Abnormal breath sounds on auscultation | 1 (2.3%) | 0 | ND |
Preliminary clinical diagnosis | |||
Upper respiratory tract infection | 36 (83.7%) | 24 (82.8%) | 0.91 |
Pulmonary infection | 1 (2.3%) | 2 (6.7%) | ND |
ND, The group in which N < 5 was not included in statistical analyses.